Global Ankylosing Spondylitis Market 2015-2019

www.technavio.com

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Global Ankylosing Spondylitis Market 2015-2019

• The report discusses the following in-depth:

• Market Segmentation by Product

• Market Segmentation by Nature of Transaction

• Demographic Segmentation

• Service Segmentation

• Business Segmentation by Revenue

• Geographical Segmentation by Revenue

For more information on the

Global Ankylosing Spondylitis Market 2015-2019,

please mail us atmedia@technavio.com

USA – CANADA – UK – CHINA – INDIA

Key Trends

TechNavio’s senior analyst says, “The Global Ankylosing Spondylitis market is driven by several factors. Presence of high unmet needs in terms of appropriate drugs is one of the major factors propelling the growth of the market. Current treatment options cannot cure the disease completely, and the drugs have a low safety profile, resulting in a high mortality rate.”

• Ankylosing spondylitis is a chronic inflammatory disease of the spine, though other joints can also be affected. It is a member of a group of spondyloarthropathies, which also include other diseases such as reactive arthritis, psoriatic arthritis, inflammatory bowel disease-related arthritis, and some subtypes of juvenile chronic arthritis.

• The Global Ankylosing Spondylitis market is expected to grow at a moderate pace with a CAGR of 5.05 percent during the period 2014-2019.

• Understanding the key drivers influencing the market

• Understanding the challenges faced by the market

• Activities of various stakeholders involved

• Enabling technologies and the roadmap

• Key focus areas for the vendors

• Major trends that will shape the future of this market

• Vendor landscape and trajectory of the market

• Conclusion

Scope of The Report

A detailed analysis of each market driver, challenge and trend is

available in our report:

Global Ankylosing Spondylitis Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

Vendor Landscape

For a full list of vendors view our report,

Global Ankylosing Spondylitis Market

2015-2019

Abbvie

Amgen

Janssen Pharmaceuticals

AbbVie is a major player in the Global Ankylosing Spondylitis market. It is a biopharmaceutical company that focuses on the development, manufacture, and marketing of pharmaceutical products worldwide. The company has a patient-centric approach, is committed to its patients, and strives to identify opportunities to craft a better result at every phase.

Amgen is one of the major players in the Global Ankylosing Spondylitis market.

Janssen Pharmaceuticals is a pharmaceutical company of Johnson & Johnson which is an American medical device, pharmaceuticals and consumer packaged goods manufacturer. Janssen provides medicines for health concerns in therapeutic areas like attention deficit hyperactivity disorder ADHD, general medicine, mental health, neurologics, pain management, and women’s health.

USA – CANADA – UK – CHINA – INDIA

Market Landscape

• The Global Ankylosing Spondylitis market is expected to grow at a moderate pace during the forecast period owing to the presence of high unmet needs and the expected launch of novel pipeline drugs.

• In addition, increase in patient assistance programs is expected to boost the growth of the market.

• Expiry of patents, high cost of drugs, and adverse effects of drugs hinder the growth of the market.

• Dominance of the market by various biologics, growing public awareness about the disease, and growing focus on emerging markets by vendors are expected to propel the growth of the market during the forecast period.

• Abbvie, Amgen, Janssen Pharmaceuticals, Merck, and Pfizer are major vendors dominating the market.

USA – CANADA – UK – CHINA – INDIA

Key Buying Criteria

Guest Bloggers

• Authenticity • Delivery • Price• Service Support

Parameter Details

Affordability The drugs used in the treatment of ankylosing spondylitis should be

affordable and priced reasonably

AvailabilityThe drugs used in the treatment of ankylosing spondylitis should be

readily available in the market

EfficacyThe drugs used in the treatment of ankylosing spondylitis should be

efficient and show positive results

SafetyThe drugs used in the treatment of ankylosing spondylitis should be

safe and have minimum adverse effects

• Growth Forecasts?

• Market Analysis?

• Revenue Forecasts?

• Regional and Country level Analysis?

• Competitive Structure?

• Emerging Trends?

• Vendor Landscape?

• Other?

How would you like to engage with TechNavio?

Global Ankylosing Spondylitis Market 2015-2019

USA – CANADA – UK – CHINA – INDIA

Reports Cover : Market Scenarios, Vendor landscape & Industry Road Maps.Option to Customize Report & Access to Analysts on every Report Purchase.

Option to Customize Reports

Ask an Analyst

Or

Inform us by e-mailing

enquiry@technavio.com

USA – CANADA – UK – CHINA – INDIA

Access the Report

USA – CANADA – UK – CHINA – INDIA

India: An Overview

USA – CANADA – UK – CHINA – INDIA

About Us

USA – CANADA – UK – CHINA – INDIA

Thank You!

North America

Chicago, USA

Phone: +1 630 333 9501

Fax: +1 630 833 2171

Europe

London, United Kingdom

Phone: +44 208 123 1770

Fax: +44 845 280 2825

Asia

Bangalore, India

Phone: +91 934 254 0560

Fax: +91 80 4080 6070

DISCLAIMER

This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making

purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of

or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.

Copyright ©2013 Infiniti Research Limited. All Rights Reserved.

Reproduction without written permission is completely forbidden.

NOT FOR FURTHER DISTRIBUTION